Human primary T cells were engineered with a Kymriah like chimeric antigen receptor (CAR) coexpressing either a control gene (left, Regular CAR T Cells) or with LTBR (right, Enhanced CAR T Cells).

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

LTBR's strategic partnership with Oklo Inc. aims to co-locate fuel fabrication facilities and explore nuclear waste recycling, enhancing cost efficiency and sustainability. Despite zero revenues ...

RESTON, Va., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced the signing of a Memorandum ...

Oklo (NYSE:OKLO) said Tuesday it signed a memorandum of understanding with Lightbridge (LTBR) to conduct a feasibility study to co-locate a Lightbridge commercial-scale fuel fabrication facility ...

In this article, we are going to take a look at where Lightbridge Corporation (NASDAQ:LTBR) stands against other industrial stocks that are skyrocketing so far in 2025. The industrial sector has ...